2011
DOI: 10.4236/scd.2011.11002
|View full text |Cite
|
Sign up to set email alerts
|

Repeated application of autologous bone marrow-derived stem cell therapy in patients with severe Buerger’s disease

Abstract: Stem cell therapy (SCT) is a promising and prospective approach in the treatment of patients with severe peripheral arterial disorders, primarily with Buerger's disease. However, very little is known about the duration of the effect of SCT, and to our best knowledge no data are available on the efficacy and safety of repeated SCT in patients with Buerger's disease. Here we report on two patients with severe Buerger's disease, who received repeated autologous bone marrow-derived stem cell therapy. Our results s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…The ideal strategy for stem cell delivery is that it should be easy to perform, minimally invasive, has very little side effects, has high cell survival and should be based on clinical settings. Moreover, under certain circumstances, the combination of more than one method may be considered [ 29 , 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…The ideal strategy for stem cell delivery is that it should be easy to perform, minimally invasive, has very little side effects, has high cell survival and should be based on clinical settings. Moreover, under certain circumstances, the combination of more than one method may be considered [ 29 , 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…Patients with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, M-protein or monoclonal gammopathy and skin changes) have improvements in forced expiratory volume and total lung capacity after receiving mononuclear cells [57,58] and nonhealing ulcers in patients with Buerger's disease treated with autologous bone marrow stem cells demonstrate accelerated healing [59]. Improvements in limb ischemia due to ischemic leg ulcers have also been reported [60][61][62][63].…”
Section: Clinical Reportsmentioning
confidence: 99%